MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD is expecting to see an additional $200 million layered onto its costs this year as a result of President Trump's tariffs – even before a possible pharma-specific levy is announced. The US pharma ...

TheStreet Pro is our premium subscription service. It offers everything you need to manage and grow your investments, including access to exclusive premium articles, TheStreet Pro's portfolio and ...

MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...

Pro bono work is a professional responsibility and an individual ethical commitment of each lawyer. The Committee launched the National Celebration of Pro Bono in 2009 because of the increasing need ...

Dongfeng Motor hits annual NEV sales of 1 million vehicles 2025 Chinese NEV roundup: A look at the year's most significant launches 【SMM Analysis】Weekly Review of Indonesian Nickel Market - Dec 26 ...

[Domestic Iron Ore Brief Review] Environmental Protection Pressure Persists, Iron Ore Concentrate Prices in the Tangshan Region May Continue to Fluctuate ...